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Abstract 
Ehlers-Danlos syndrome (EDS) comprises a group of heritable connective tissue 
disorders which has as cardinal features varying degrees of skin hyperextensibility, 
joint hypermobility, easy bruising and skin fragility. The 2017 New York nosology 
distinguishes 13 types of EDS, which all, except hypermobile EDS, have a known 
molecular basis. Hypermobile EDS is recognized as a common and often disabling 
disorder, incorporating benign joint hypermobility syndrome. EDS needs to be 
differentiated from other connective tissue disorders, in particular Marfan 
syndrome, Loeys-Dietz syndrome and cutis laxa. The frequent types of EDS can be 
diagnosed after careful history taking and clinical examination, but for definite 
diagnosis, molecular confirmation is needed in all types. Management for EDS 
patients preferably is provided by multidisciplinary teams in expertise centres. After 
diagnosing EDS, genetic counselling is an essential part of the management of 
patients and their family. 
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INTRODUCTION 
 EDS comprises a clinically and genetically 
heterogeneous group of heritable connective tissue 
disorders (HCTD), mainly characterized by a variable 
degree of generalized joint hypermobility, skin 
hyperextensibility, easy bruising and skin fragility.  In 
his classical monograph on EDS, published in 1970, 
Beighton described 5 EDS types: I = gravis (severe), II 
= mitis (mild), III = hypermobility, IV = ecchymotic, and 
V = X-linked.1 The Berlin classification listed 11 EDS 
types.2 Revision became necessary because of new 
biochemical, molecular and clinical data, leading to the 
Villefranche nosology of 1997, in which 6 EDS types 
were recognized.3 New clinical and molecular data 
required another revision, which was initiated during the 
Ehlers-Danlos Society International Symposium in New 
York, May 2016, the results of which have been 
published in the March 2017 issue of the American 
Journal of Medical Genetics Part C, Seminars in Medical 
Genetics.  
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The most striking changes were: 
- incorporating EDS types which were published 
since the Villefranche nosology, leading to a total 
number of 13 types.4 
- deciding - not unexpectedly though - that EDS 
hypermobility type and benign joint hypermobility 
syndrome (BJHS; also called joint hypermobility 
syndrome or hypermobility syndrome) are in fact 
part of one and the same clinical spectrum ranging 
from apparently symptomatic generalized joint 
hypermobility to the more disabled individuals 
fitting the new diagnostic criteria. These new criteria 
are more strict than the Villefranche criteria and the 
Brighton criteria for BJHS in order to define a 
homogeneous phenotype for management and 
scientific purposes. Its name is hypermobile EDS. 
 
 It always has been, and still is, a challenge to classify 
individual patients in one of the existing EDS types. 
Often this is not possible and therefore there is still room 
for new types. This is, among other things, due to: 
- the clinical overlap between many of these EDS 
types 
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- absence of a pathogenic variant in any of the known 
EDS associated genes in an important proportion of 
EDS patients. 
- the presence of associated features which do not fit 
into one of the existing types. 
- the absence of a laboratory test for hypermobile 
EDS. 
 
 EDS is not a rare disorder; the prevalence is 
estimated to be about 1:5000. The hypermobile type - by 
far the most common - and the classical type comprise 
more than 90% of all cases.5 
 
CLASSIFICATION AND NOSOLOGY  
 The New York classification is based on clinical, 
biochemical and molecular data.4 Table 1 shows the 
New York nosology alongside the previous nosologies 
with inheritance patterns, genetic bases and proteins, 
while in table 2, EDS types are grouped according to 
underlying genetic and pathogenetic mechanisms; 
OMIM numbers are added.  
In clinical practice, the clinical manifestations guide the 
choice for further investigations. The major clinical 
manifestations of EDS need some clarification, 
however.  
 Skin hyperextensibility should be tested at specific 
sites, e.g. the volar side of the non-dominant forearm or 
the dorsum of the hand by pulling up the skin until 
resistance is felt. In contrast to cutis laxa, a group of 
clinically and genetically heterogeneous disorders 
characterised by redundant, sagging and inelastic skin, 
with or without joint hypermobility, in EDS the skin 
snaps back after release.6 The upper limit of normal for 
the forearm and dorsum of the hand is about 1 ½ cm.7 In 
young children, it is difficult to assess hyperextensibility 
due to the abundance of subcutaneous fat. Skin 
hyperextensibility can also be assessed at the dorsal 
aspect of the elbow in 900 flexion, where the upper limit 
of normal is 3 cm.  
 Joint hypermobility is scored using the Beighton 
mobility scale (table 3). In the New York nosology, a 
score of 5/9 or more defines generalized hypermobility in 
both sexes, though it is known that joint mobility 
depends, apart from age, family and ethnic background, 
also on gender. Since laxity decreases with age, patients 
with a Beighton score <5/9 may be considered positive 
based on their historical observations (five-point 
questionnaire = 5PQ; see footnote with table 4). For the 
diagnosis of hypermobile EDS different age and sex 
specific cut-off points were proposed (see table 4). In 
Table 1 Classification of Ehlers-Danlos syndrome (adapted from4) 
Berlin 
classification 
(1988) 
11 types 
Villefranche 
classification 
(1997) 
6 types 
International 
classification 
(2017) 
13 types 
IP  Genetic basis Protein 
Type I (gravis) 
and type II 
(mitis)  
Classical type Classical EDS 
cEDS  
AD Major: COL5A1, COL5A1  
Rare*: COL1A1  
c.934C>T, p.(Arg312)  
Type V collagen  
Type I collagen 
  Classical-like EDS 
clEDS 
AR TNXB  Tenascin XB 
  Cardiac-valvular EDS 
cvEDS  
AR COL1A2 (biallelic mutations that 
lead to COL1A2 NMD and 
absence of pro a2(I) collagen 
chains) 
Type I collagen 
 
Type 
IVA,B,C,D 
Vascular type Vascular EDS 
vEDS 
AD Major: COL3A1 
Rare: COL1A1  
c.934C>T, p.(Arg312Cys) 
c.1720C>T, p.(Arg574Cys)  
c.3227C>T, p.(Arg1093Cys)  
Type III collagen 
Type I collagen 
 
Type III Hypermobility 
type 
Hypermobile EDS 
hEDS 
AD Unknown                                 Unknown 
Type VIIA and 
B 
Arthrochalasia 
type 
Arthrochalasia EDS 
aEDS 
AD COL1A1, COL1A2  Type I collagen 
Type VIIC Dermatosparaxis 
type 
Dermatosparaxis EDS 
cEDS 
AR ADAMTS2  ADAMTS-2 
Type VIA  Kyphoscoliotic 
type 
Kyphoscoliotic EDS 
kEDS 
AR  PLOD1   
FKBP14   
LH1 
FKBP22 
Type VIB  Brittle cornea 
syndrome  
BCS 
AR ZNF469   
PRDM5   
ZNF469 
PRDM5 
  Spondylodysplastic 
EDS  
spEDS 
AR B4GALT7   
B3GALT6   
SLC39A13 
b4GalT7 
b3GalT6 
ZIP13 
Type VIB  Musculocontractural 
EDS  
mcEDS 
AR CHST14 
DSE   
D4ST1  
DSE 
  Myopathic EDS 
mEDS 
AD/ 
AR 
COL12A1  Type XII collagen 
EDS VIII  Periodontal EDS 
pEDS 
AD C1R  
C1S  
C1r   
C1s 
IP: inheritance pattern 
NMD: nonsense mediated decay 
* EDS classical type with (propensity to) arterial rupture.12 
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children under the age of about 5 years, the Beighton 
scale is less useful.  
 Generalised hypermobility is not rare: 5-10% of – 
mainly female – secondary school age Caucasian 
children is hypermobile and this percentage is higher in 
Asian populations.7,8  
 Easy bruising is seen as spontaneous ecchymoses, 
frequently recurring in the same bodily regions, of which 
long-term signs are often visible as brownish 
discoloration (haemosiderin), in particular on knees and 
shins. If it is the predominant presenting sign, child abuse 
and bleeding disorders need to be considered first.  
Tissue fragility is manifested in the skin as easy bruising 
and impaired wound healing with dystrophic scars, which 
are usually found over pressure points like forehead, 
chin, elbow, knee and shin and which may have a wide 
Table 3 Beighton mobility scoring scale* 
Joint  Negative Unilateral Bilateral 
Passive dorsiflexion of the 5th 
finger > 90o 
0 1 2 
Passive flexion of thumbs to the 
forearm 
0 1 2 
Hyperextension of the elbows > 
10o 
0 1 2 
Hyperextension of the knees > 
10o 
0 1 2 
Forward flexion of the trunk with 
knees fully extended and palms 
resting on the floor 
0 1 
Maximum total score  9 
* a score of 5/9 or more defines generalized joint hypermobility for both sexes (for hypermobile EDS age and sex related 
cut-off points are used; see table 4) 
 
Table 2 EDS grouping according to underlying genetic and pathogenetic mechanisms (adapted from4) 
Berlin or earlier name Villefranche name New York name OMIM Gene  
GROUP A: Disorders of collagen primary structure and collagen processing 
EDS I 
EDS  II 
Classical type Classical EDS (cEDS) 130000 COL5A1 
COL5A2 
EDS IV Vascular type Vascular EDS (vEDS) 130010 COL3A1 
EDS VIIA 
EDS VIIB 
Arthrochalasia type  Arthrochalasia EDS (aEDS) 130060 
130080 
Type I collagen 
EDS VIIC Dermatosparaxis type Dermatosparaxis EDS (dEDS) 225410 ADAMTS2 
Cardiac-valvular EDS ----- Cardiac-valvular EDS (cvEDS) 225320 Type 1 collagen 
GROUP B: Disorders of collagen folding and collagen cross-linking 
Ocular-scoliotic EDS 
EDS VI/VIA 
Kyphoscoliotic type Kyphoscoliotic EDS (kEDS-
PLOD1) 
225400 PLOD1 
---- ---- Kyphoscoliotic EDS (kEDS-
FKBP14) 
614557 FKBP14 
GROUP C: Disorders of structure and function of myomatrix, the interface between muscle and ExtraCellular 
Matrix 
---- ---- Classical-like EDS (clEDS) 606408 TNXB 
---- ---- Myopathic EDS (mEDS) 616471 COL12A1 
GROUP D: Disorders of glycosaminoglycan biosynthesis 
EDS progeroid type 1 ---- Spondylodysplastic EDS 
(spEDS-B4GALT7) 
130070 B4GALT7 
EDS progeroid type 2 ---- Spondylodysplastic EDS 
(spEDS-B3GALT6) 
615349 B3GALT6 
Adducted thumb-
clubfoot syndrome 
Musculocontractural 
type 
EDS Kosho type 
D4ST1 deficient EDS 
---- Musculocontractural EDS 
(mcEDS-CHST14) 
601776 CHST14 
---- ---- Musculocontractural EDS 
(mcEDS-DSE) 
615539 DSE 
GROUP E: Disorders of complement pathway  
EDS VIII Periodontitis type Periodontal EDS (pEDS) 130080 C1R, C1S 
GROUP F: Disorders of intracellular processes (provisional) 
Spondylocheirodysplast
ic EDS 
---- Spondylodysplastic EDS  
(spEDS-SLC39A13) 
612350 SLC39A13 
Brittle cornea 
syndrome 
---- Brittle cornea syndrome (BCS) 229200 
614170 
ZNF469 
PRDM5 
Unresolved form of EDS 
EDS III Hypermobility type Hypermobile EDS (hEDS) 130020 ?? 
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and papyraceous appearance. Internal organs like 
arteries, lungs, intestines, liver, spleen and uterus may 
also show fragility, predominantly in the vascular type. 
 Some features are regularly observed, but are not 
criteria of generalised hypermobility syndromes. One 
example is the ineffectiveness of local anaesthetics in 
hypermobile EDS.9 
 Table 4 shows the major and minor diagnostic 
criteria, minimal criteria for diagnosis and how to verify 
the diagnosis. 
 A major diagnostic criterion has high diagnostic 
specificity, which means that it is present in the vast 
majority of the affected individuals and/or it is 
characteristic for the disorder and allows differentiation 
from other EDS types and/or other HCTD. A minor 
criterion is a sign of lesser diagnostic specificity, but its 
presence supports the diagnosis. However, in the 
absence of major criteria, minor criteria are not sufficient 
for a given diagnosis. Because of the vast genetic 
heterogeneity and phenotypic variability of the EDS 
types and the clinical overlap between many of these, the 
definite diagnosis relies for all types, except the 
hypermobile type, on molecular confirmation. 
 In older publications, features like facial 
dysmorphisms and mental retardation/intellectual 
disability were attributed to EDS, whereas nowadays 
these features are not any longer considered 
characteristics of EDS, except for facial dysmorphisms 
in vascular, dermatosparaxis, spondylodysplastic and 
musculocontractural EDS and intellectual disability in 
spondylodysplastic EDS (see table 4). Explanation for 
this could be that other syndromes associated with these 
features were erroneously diagnosed as EDS because of 
overlapping features with EDS. Another explanation is 
that these other features are not rare and consequently 
are found associated with EDS in a low percentage of 
cases. 
 The classical EDS has all the skin and joint 
characteristics of EDS, though in variable range of 
severity. Minimal diagnostic criteria are the presence of 
skin hyperextensibility and atrophic scars, plus either 
generalized joint hypermobility and/or 3 minor criteria 
(for details see table 4).10 A recent paper reviewed 62 
molecularly confirmed cases from Italy.11 It is inherited 
in an autosomal dominant fashion. However, sporadic 
cases (i.e. without an affected parent) do occur due to a 
spontaneous mutation. Genetically, it is heterogeneous 
since in over 90% of patients, who fulfil all major 
criteria, a defect can be found in (products of) one of the 
two genes that are up to now known to be involved, 
COL5A1 and COL5A2. An EDS type resembling the 
classical type but clinically characterized by a propensity 
to arterial rupture and molecularly by a specific mutation 
in COL1A1 (c.934C>T; p.Arg312Cys) is regarded as a 
variant type of classical EDS.12,13 The major differential 
diagnosis of the classical type, at least in a sporadic case, 
is the classical-like EDS. Also, in mild cases of the 
classical type (partial expression), differentiation from 
the hypermobile type might be difficult, if not 
impossible.  
 Classical-like EDS resembles the classical type, 
however with normal wound healing and scar 
formation.13,14 Minimal diagnostic criteria are the 
presence of all 3 major criteria, i.e. skin 
hyperextensibility, generalized joint hypermobility and 
easy bruisability and a family history compatible with 
autosomal recessive inheritance. It is characterised by 
generalized hypermobility, with a remarkable laxity of 
finger joints. In contrast with the classical type, its 
inheritance is autosomal recessive, so most cases are 
sporadic and some occur in sibships. It is due to tenascin-
X deficiency. In serum, tenascin-X is completely absent 
and mutation analysis  of the TNX-B gene reveals bi-
allelic mutations.  
 The cardiac valvular EDS is rare.13,15 Apart from 
typical EDS features, it is associated with severe aortic 
and/or mitral valve insufficiency, necessitating valve 
replacement at relatively young age. Minimal diagnostic 
criteria are the presence of severe progressive cardiac-
valvular problems, family history compatible with AR 
inheritance plus either one other major criterion and/or at 
least 2 minor (for details see table 4). The inheritance is 
autosomal recessive. It is due to homozygous or 
compound heterozygous COL1A2 null mutations.  
 The vascular EDS is the most severe form of EDS.16 
Minimal diagnostic criteria are the presence of a family 
history of vascular EDS, arterial rupture/dissection <40 
years, unexplained sigmoid colon rupture or spontaneous 
pneumothorax in the presence of other features consistent 
with vascular EDS. These and a combination of minor 
criteria warrant verifying diagnostic tests, i.e. DNA 
analysis (for details see table 4). Diagnosis in children is 
difficult, particularly in the absence of a family history. 
The vascular type is inherited in an autosomal dominant 
fashion. Arterial rupture is the most common cause of 
sudden death and has its peak incidence in the 3rd or 4th 
decade. Acute abdominal and flank pain is a common 
presentation of an arterial or intestinal rupture and needs 
urgent investigation and treatment. Frank et al. showed 
that the type of COL3A1 mutation is associated with the 
phenotype and severity: patients with glycine 
substitutions, splice-site mutations and in-frame 
insertions–deletions have a more severe phenotype, 
including digestive events, compared to e.g. mutations 
leading to non-glycine missense variants or haplo-
insufficiency, due to a null allele. The latter may delay 
onset of complications by almost 2 decades.16,17 A recent 
study showed that vEDS is characterized by a high 
frequency of de novo pathogenic variants, while parental 
mosaicism was rare.18  
 For women with the vascular type, pregnancy and 
delivery pose specific risks, which warrant pre-
conceptional counselling with an experienced 
obstetrician and clinical geneticist.19 
There is considerable clinical overlap between the 
vascular type and Loeys-Dietz syndrome type 1 and 2 
(OMIM 609192 and 610168 respectively), which are due 
to TGFBR1 (type 1) and TGFBR2 (type 2) mutations.20 
Also other aortic aneurysm syndromes, such as Marfan 
syndrome, Thoracic Aortic Aneurysm and Dissection 
(TAAD), annulo-aortic ectasia should be included in the 
differential diagnosis.21  
 The hypermobile EDS, incorporating BJHS, is 
dominated by generalized joint hypermobility and its 
possible sequelae, in particular chronic pain, which can 
be severe and invalidating, and possibly early 
osteoarthritis.22 As said before, the new diagnostic 
criteria are more strict than the Villefranche criteria and 
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the Brighton criteria.4 The clinical diagnosis of 
hypermobile EDS needs the simultaneous presence of 3 
criteria: criterion 1 = generalized joint hypermobility, 
criterion 2 = 2 or more of the features A, B and C (A = 
systemic manifestations of a more generalized 
connective tissue disorder; B = positive family history; 
C = musculoskeletal complications) and criterion 3 = 
absence of unusual skin fragility and exclusion of 
alternative diagnosis (for details see table 4). Recently, 
also cardiovascular dysautonomia (mainly postural 
tachycardia syndrome = POTS), functional gastro-
intestinal manifestations, sleep disturbance, fatigue, 
depression and anxiety disorders have been attributed to 
hypermobile EDS, but these are at the moment not 
sufficiently sensitive nor specific. Basically, there is no 
confirmative laboratory test for the hypermobility type, 
meaning that it is a purely clinical diagnosis. In 2015, 
Syx et al. reported linkage to chromosome 8p22-8p21.1 
in a 3 generation Belgian family with EDS 
hypermobility type, whereby whole exome sequencing 
revealed a possibly involved gene.23 Up to recently, 
BJHS was considered a separate entity with its own 
diagnostic criteria.24 It was already argued earlier that the 
hypermobility type and BJHS are in fact one and the 
same disorder with variable expression. Arguments put 
forward for this were among others the fact that haplo-
insufficiency of TNX-B, assessed as about half of the 
normal activity of tenascin-X in blood, and/or 
heterozygosity for a pathogenic TNX-B mutation, is 
found both in cases with EDS hypermobility type and 
cases in whom BJHS is the more likely diagnosis.25 Also, 
a changing phenotype from one diagnosis into the other 
in one individual and in some pedigrees the occurrence 
of both diagnoses argued for this statement.26 
 Castori et al. proposed a framework for the 
classification of joint hypermobility and related 
syndromes.27  
 The arthrochalasia EDS is also rare, but diagnosable 
at birth.13 Minimal criteria suggestive for arthrochalasia 
EDS are congenital bilateral hip dislocation plus either 
skin hyperextensibility or severe generalized joint 
hypermobility with multiple dislocations/subluxations 
and at least 2 other minor criteria (for details see table 
4). It is inherited in an autosomal dominant fashion. It is 
due to specific mutations in COL1A1 or COL1A2. 
Larsen syndrome, which also features congenital 
luxations, should be in the differential diagnosis. 
 The dermatosparaxis EDS derives its name from a 
similar phenotype and biochemical defect in cattle, 
sheep, and other animals.13 It is the EDS type which has 
the closest resemblance to cutis laxa. However, in cutis 
laxa there is neither fragility nor bruising. Its mode of 
inheritance is autosomal recessive. It is one of the rarest 
of all types and since only very few cases have been 
described, possibly this type is characterised by other - 
as yet unrecognised - features. Recently, Van Damme et 
al. expanded the phenotype and suggested new 
diagnostic criteria.28 The New York nosology requires 
for its diagnosis extreme skin fragility with congenital or 
postnatal skin tears AND characteristic craniofacial 
features plus either 1 other major and/or 3 minor criteria 
(for details see table 4). It is due to bi-allelic mutations 
in ADAMTS2. The mode of inheritance is autosomal 
recessive. 
 The kyphoscoliotic EDS is a rare but severe form of 
EDS, manifesting itself often at or shortly after birth.13,29 
The presence of congenital muscle hypotonia AND 
congenital or early onset kyphoscoliosis plus either 
generalized joint hypermobility and/or 3 minor criteria 
(either general or PLOD1 and FKBP14 gene-specific) 
warrants laboratory testing. Kyphoscoliotic EDS is 
genetically heterogeneous and can be caused by 
mutations in PLOD1 and FKBP14. Laboratory tests 
should start with measurement of the urinary lysyl and 
hydroxy-lysyl pyridinoline ratio. An increased ratio has a 
very high degree of sensitivity and specificity for PLOD1 
mutations, but not for FKBP14 mutations (for details and 
molecular tests: see table 4). The mode of inheritance is 
autosomal recessive. Because of severe hypotonia, 
patients very often undergo a full scale neuromuscular 
work-up, including a muscle biopsy before the diagnosis 
is established. The differential diagnosis comprises all 
other causes of severe hypotonia, including neonatal 
Marfan syndrome.  
 The even rarer brittle cornea syndrome resembles the 
kyphoscoliotic type, but is generally milder.13,30 Minimal 
diagnostic criteria are thin cornea with or without rupture 
plus either at least one other major criterion and/or 3 
minor criteria (for details see table 4). It shows a normal 
urinary lysyl and hydroxy-lysyl pyridinoline ratio, and is 
characterised by mutations in the genes ZNF469 or 
PRDM5.  
 Spondylodysplastic EDS is genetically heterogeneous 
and is due to bi-allelic mutations in either B4GALT7 
(former name progeroid type 131), B3GALT6 (former 
name progeroid type 232) or SLC39A13 (former name 
spondylocheirodysplastic type33).13 There is considerable 
overlap with kyphoscoliotic EDS. Minimal diagnostic 
criteria are short stature AND muscle hypotonia plus 
characteristic radiographic abnormalities and at least 3 
other minor criteria (general or gene-specific; see table 
4). 
 The urinary lysysl and hydroxylysyl pyridinoline 
ratio is moderately increased (to approximately 1 
compared to normal values of ~ 0.2) with HLPC for 
SLC39A13 mutations. Van Damme et al. described 
recently 12 patients with bi-allelic B3GALT6 mutations.34  
 The musculocontractural EDS is due to bi-allelic 
mutations in either CHST14 gene (type 1) or more rarely 
DSE gene (type 2) and has also considerable clinical 
overlap with the kyphoscoliotic type.13,35 Uehara et al. 
described spinal involvement in 12 patients with CHST14 
related mcEDS.36 Minimal diagnostic criteria are at birth 
or in early childhood congenital multiple contractures 
AND characteristic craniofacial features, while in 
adolescence and adulthood these are congenital multiple 
contractures AND characteristic cutaneous features (for 
details see table 4).  
 Myopathic EDS is caused by heterozygous or bi-
allelic mutations in COL12A1.13,37 Minimal diagnostic 
criteria are congenital muscle hypotonia and/or muscle 
atrophy that improves with age plus either one other 
major criterion and/or three minor criteria (for details see 
table 4). The phenotype highly overlaps with collagen VI 
type related myopathies, i.e. Bethlem myopathy and 
Ullrich Congenital Muscular Dystrophy. 
 The periodontal EDS has some overlap with the 
classical type, but has progressive and aggressive 
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periodontitis as a distinguishing feature.13 Minimal 
diagnostic criteria are severe, intractable periodontitis of 
early onset (childhood or adolescence) OR lack of 
attached gingiva plus at least 2 other major criteria and 
one minor criterion (for details see table 4). In 2016, it 
was found that gain-of-function mutations in the C1R 
gene or the C1S gene, encoding serine proteinases, cause 
periodontal EDS.38 Recently, leukencephalopathy and 
peri-implant disease were described as  additional 
features of pEDS.39,40  
 In 2016, bi-allelic AEBP1 mutations were described 
in an autosomal recessive EDS variant, featuring joint 
hypermobility with joint dislocations, hyperextensible, 
translucent and redundant skin, poor wound healing with 
abnormal scarring, easy bruising and gastrointestinal, 
urogenital, cardiovascular and skeletal abnormalities. Its 
features overlap with several EDS types, particularly 
cEDS, mcEDS and spEDS. So far, 8 patients with bi-
allelic AEBP1 mutations have been described. AEBP1 
encodes ACLP, that associates with collagens in the 
extracelleular matrix (ECM) and is highly expressed in 
collagen rich tissues like skin, vasculature and 
connective tissues.41,42,43,44 In OMIM it can be found 
under 618000, named EDS classic-like, 2. This new EDS 
variant is not added in any of the tables 1, 2, and 4. 
 The former EDS type V (X-linked) has been 
described in only 2 families and is not any longer 
accepted as belonging to the EDS spectrum; the same 
holds true for the former fibronectin deficient type X, 
familial articular hypermobility EDS XI and Filamin A 
related EDS with heterotopia. The former type IX is an 
X-linked cutis laxa disorder and is renamed occipital 
horn syndrome; it is due to mutations in the gene ATP7A, 
the same gene as is mutated in Menkes syndrome 
(disorder of copper metabolism).  
 For further reading, the excellent reviews by Malfait 
et al. and Byers and Murray are highly recommended.4,45 
The whole March 2017 issue of the American Journal of 
Medical Genetics Part C, Seminars in Medical Genetics 
provided a very good update not only about EDS 
nosology and diagnostic criteria, but also about 
management aspects of the various types of EDS. 
Management for EDS patients preferably is provided by 
multidisciplinary teams in expertise centres. However, 
in a recent literature study concerning clinical practice 
guidelines specifically addressed to EDS the total 
absence of such guidelines was noted and many clinician 
and patient unmet needs were identified.46  
 Joint hypermobility is a symptom of large variety of 
syndromes. Among these, one finds - not surprisingly - 
other heritable connective tissue disorders like cutis laxa, 
osteogenesis imperfecta, Stickler syndrome, Loeys-
Dietz syndrome and Marfan syndrome, but also skeletal 
dysplasias, inborn errors of metabolism, neuromuscular 
disorders, chromosomal abnormalities and syndromes 
like Larsen syndrome, Fragile X syndrome and Langer-
Giedion syndrome. 
 
HOW TO REACH THE DIAGNOSIS EHLERS-
DANLOS SYNDROME, INCLUDING CORRECT 
TYPING? 
 Like always in clinical practice, the results of history 
taking, including a family history, and physical 
examination are the basis for planning additional 
investigations and finally reaching a diagnosis. 
Additional investigations are often biochemical as a first 
screen, followed by targeted DNA analysis. However, 
with the introduction of new DNA technologies, like next 
generation sequencing (NGS), rapid search for the 
disease causing mutation by molecular analysis of all 
known EDS genes (“the EDS panel”) at once has become 
possible. This is already standard routine diagnostic 
practice in many laboratories and will become routine in 
all in the near future. Copy number variation analysis for 
large deletions and duplications has also a place in the 
molecular analysis in cases where NGS did not reveal a 
mutation in AD types and only one mutation in AR types, 
while whole exome sequencing and whole genome 
sequencing will be indicated in the search for new types 
when all tests are negative. 
 As history taking and physical examination in relation 
to EDS are very important, these will be discussed below. 
 Good history taking starts with identifying the exact 
symptoms and complaints, which compelled the patient 
to see a physician: when and how did they start and 
evolve, how were they treated (what were the results, 
what was advised/prescribed and by whom?). Specific 
questions should elucidate the presence or absence of: 
- Hypermobility and/or (sub)luxations. If 
(sub)luxation occurred: which joint(s) was/were 
involved, how often did it occur, was it spontaneous 
(also the first time) and painful? Was it seen/treated 
by doctors? If necessary also the Five-Point 
Questionnaire (5PQ; see footnote in table 4). 
Contractures? Congenital hip dislocation?47,48  
- Painful joints.49 If so: which ones, when, under 
which circumstances, exercise related, warm and 
swollen, if so, for how long? Use of analgesics? 
Sprains? What are the major limitations in daily 
life? 
- Temporomandibular joint problems.50 
- Problems with bursae/tendons. 
- (Spontaneous) fractures. 
- Skin fragility and abnormal wound healing with 
wide atrophic scars. 
- Surgery, e.g. for inguinal hernia. If so: 
complications? 
- Easy bruising and/or abnormal menstrual bleeding. 
- Abnormal exercise tolerance and/or fatigue.51 
Sports performed? Type of work: blue or white 
collar? 
- Pneumothorax? 
- Cardiac problems? Cardiovascular autonomic 
dysfunction?52 
- Genito-urinary tract problems, e.g. uterine prolapse, 
voiding dysfunction.  
- Gastro-intestinal tract problems, e.g. constipation, 
diverticula, rectal prolapse.53 
- For female patients with children: pregnancy and 
delivery problems.19  
- Rupture of internal organs (arteries, lungs, 
intestines, spleen, uterus). 
- Psychiatric problems, like anxiety, depression, 
ADHD?54 
- Neurological problems?55,56 Headache? Migraine? 
- Eye problems, e.g. refractive errors, abnormal 
vision. 
- Hearing? 
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- Growth? 
- Motor and cognitive development? 
- Dental problems? 
- Miscellaneous: Gingivitis? Varicose veins? 
Abnormal effect of local anaesthesia? 
 
The family history includes drawing a three generation 
pedigree with specific enquiry regarding hypermobility, 
easy bruising, abnormal scarring, arterial dissections and 
organ ruptures.  
 The physical examination is focused on signs 
relevant for connective tissue disorders: 
- Build and biometry: height, weight, span and others 
when indicated. Marfanoid? 
- Facial features: among others, Gorlin sign (ability 
to touch the tip of the nose with the tip of tongue)? 
High palate? Absence of subcutaneous fat? 
Prominent eyes? Thin, “pinched” nose? Normal 
earlobes? Epicanthic folds? Low-set ears? 
Midfacial hypoplasia? Micrognathia? Down-
slanting palpebral fissures? Gingival recession? 
- Teeth: dental crowding? Discoloured? Dysplastic? 
Periodontitis? 
- Thorax: deformity? 
- Back: (kypho)scoliosis? 
- Extremities: Beighton score; arachnodactyly (wrist 
and thumb sign)? (Sub)luxations? Brachydactyly? 
Contractures? Flat feet? Joints? Muscle strength? 
Hallux valgus? 
- Skin: extensibility? Texture? Thickness and venous 
pattern? Striae distensae? Varicose veins? 
Piezogenic papules? Molluscoid pseudotumors? 
Spheroids? Scars? Herniae? 
- Eyes: blue sclerae? Microcornea? Strabismus? 
Clouded cornea? Glaucoma? Scleral/ocular 
fragility? Keratoconus? 
- Neurological examination: muscle weakness? 
Reduction in vibration sense? Reduction of tendon 
reflexes? 
 
 After history taking, a differential diagnosis will be 
established, on which basis additional investigations, 
such as biochemical and/or DNA analysis in blood 
and/or cultured fibroblasts, derived from a skin biopsy, 
are planned, if clinically relevant and available for the 
suspected type(s). Morphological examination of a skin 
biopsy is of limited value, except in some types, 
particularly in dermatosparaxis EDS. On indication, the 
patient will be referred to an ophthalmologist, 
cardiologist, orthopaedic surgeon, neurologist and/or 
others. 
 DNA analyses are available as diagnostic services in 
most of the high and middle income countries. As 
already indicated, there is no DNA test available for 
hypermobile EDS. If there is any reason to believe the 
phenotype could be the classical-like, tenascin-X 
deficient type, then there is an indication to perform 
tenascin-X analysis in serum. If there is suspicion of 
vascular EDS, the threshold to do DNA analysis should 
be very low, because of the consequences of that 
diagnosis in terms of management and genetic 
counselling. For some of the other EDS types the same 
holds true, because of their severity, rareness, 
overlapping features with other EDS types and/or 
different modes of inheritance. In fact, for definite 
diagnosis molecular confirmation is needed for all types, 
except the hypermobile type. 
 
GENETIC COUNSELLING 
 Since all the disorders which have been discussed 
have a genetic background, genetic counselling is an 
indispensable part of the management of patients and 
their families. During genetic counselling, information 
will be given about the mode of inheritance, recurrence 
risk, variability and penetrance of the disorder, the 
possibilities of prenatal diagnosis and diagnosis in 
relatives at risk and management. Prenatal diagnosis and 
diagnosis in relatives at risk is only possible if the 
causative DNA defect is known. A social worker should 
be available to assist whenever a need is perceived or 
requested. When there is a patient/parent support group, 
patients/parents should be informed. In case of a proband 
of non-EDS parents, it is essential to differentiate 
between an autosomal dominant (e.g. classical type) and 
an autosomal recessive type (e.g. classical-like, tenascin-
deficient type): in the classical type the recurrence risk 
for a next child of these non-EDS parents is low (less than 
1%) and for a child of the affected patient high (50%), 
while in the tenascin-deficient type the recurrence risk for 
a next child is high (25%) and for a child of the affected 
patient generally low (1% or less). It is important to be 
aware of the possibility of parental mosaicism in cases 
which are apparently de novo.18 
 
CONCLUSION 
 EDS is a fairly common, clinically and genetically 
heterogeneous disorder, belonging to the heritable 
disorders of connective tissue. The latest official 
classification of 2017 recognized 13 types. Since then 
another variant has been described and there is still room 
for the identification of other types. In individual patients 
it is a challenge to correctly type EDS, even after careful 
history taking and physical examination. Often a 
molecular diagnosis is needed for correct typing and 
NGS is thereby of great help. Management is preferably 
provided by a multidisciplinary team in expert centres. 
Genetic counselling is an integral part of its management.  
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Table 4 Diagnostic criteria, minimal criteria and verification of Ehlers-Danlos syndromes (data extracted from4) 
 
Types of 
EDS 
Major diagnostic 
criteria 
Minor diagnostic criteria Suggestive minimal 
criteria for diagnosis 
Verification of clinical 
diagnosis 
Classical 
EDS 
Skin 
hyperextensibility and  
atrophic scars 
Generalized joint 
hypermobility 
Easy bruising 
Smooth, velvety skin 
Skin fragility (or traumatic 
splitting) 
Molluscoid pseudotumors 
Subcutaneous spheroids 
Hernia (or history thereof) 
Epicanthic folds 
Complications of joint 
hypermobility e.g. sprains, 
(sub)luxations, pain, pes planus 
First degree relative fulfilling 
clinical criteria 
Skin 
hyperextensibility and  
atrophic scars, plus 
either generalized 
joint hypermobility 
and/or 3 minor criteria 
 
Molecular screening of a 
targeted EDS gene panel, 
including at least COL5A1, 
COL5A2, COL1A1 and 
COL1A2. 
When not available 
transmission electron 
microscopy (TEM) of skin 
biopsy (collagen flowers) 
might be supportive 
Classical-
like EDS 
Skin 
hyperextensibility 
with velvety skin 
texture and absence of 
atrophic scarring 
Generalized joint 
hypermobility with or 
without recurrent 
dislocations 
Easy bruisable 
skin/spontaneous 
ecchymoses 
Foot deformities: broad/plump 
forefoot, brachydactyly, pes 
planus, hallux valgus, 
piezogenic papules 
Edema of legs 
Mild proximal and distal 
muscle weakness 
Axonal polyneuropathy 
Atrophy of hand and foot 
muscles 
Acrogeric hands, mallet 
finger(s), clinodactyly, 
brachydactyly 
Vaginal/uterus/rectal prolapse 
All 3 major criteria 
and a family history 
compatible with 
autosomal recessive 
inheritance 
Molecular analysis of TNXB 
gene. If necessary CNV 
analysis for deletions. 
Complete absence of TNX in 
serum. 
Cardiac-
valvular 
EDS 
Severe progressive 
cardiac-valvular 
problems 
Skin 
hyperextensibility, 
atrophic scars, thin 
skin, easy bruising 
Generalized or small 
joints hypermobility 
Inguinal hernia 
Pectus deformity (mostly 
excavatum) 
Joint dislocations 
Foot deformities: pes 
(plano)valgus, hallux valgus 
Severe progressive 
cardiac-valvular 
problems AND family 
history compatible 
with AR inheritance 
plus either one other 
major criterion and/or 
at least 2 minor  
Molecular screening by 
Sanger sequencing of 
COL1A2 or targeted 
resequencing of a EDS gene 
panel. If necessary CNV 
analysis for deletions and 
duplications. 
Total absence of (pro)α2(I) 
with SDS PAGE 
Vascular 
EDS 
Family history of 
vEDS with molecular 
confirmation 
Arterial rupture at 
young age 
Spontaneous sigmoid 
colon perforation 
3rd Trimester uterine 
rupture 
Carotid-cavernous 
sinus fistula 
(Last 3: in the absence 
of other explanations) 
Bruising without trauma and/or 
in unusual sites (cheeks, back) 
Thin, translucent skin with 
increased venous visibility 
Characteristic facial appearance 
Spontaneous pneumothorax 
Acrogeria 
Talipes equinovarus 
Congenital hip dislocation 
Hypermobility of small joints 
Tendon and muscle rupture 
Keratoconus  
Gingival recession and fragility 
Early onset varicose veins (<30 
years and  nulliparous if female) 
A family history of 
vEDS, 
rupture/dissection <40 
years, unexplained 
sigmoid colon rupture 
or spontaneous 
pneumothorax in the 
presence of other 
features consistent 
with vEDS, a 
combination of other 
minor criteria should 
all lead to verifying 
diagnostic tests. 
Molecular screening by 
Sanger sequencing of 
COL3A1 or targeted 
resequencing of a EDS gene 
panel, including COL3A1 and 
COL1A1.   
If necessary CNV analysis for 
deletions and duplications. 
 
 
Hypermob
ile EDS 
Generalized joint 
hypermobility (GHJ) 
assessed by Beighton 
score 
≥ 6 for prepubertal 
children and 
adolescents 
≥ 5 for pubertal men 
and women up to the 
age of 50 
≥ 4 for those > 50 
years of age 
If the Beighton score 
is 1 point below the 
age- and sex-specific 
A: systemic manifestations of a 
more generalized connective 
tissue disorder 
1. unusually soft or velvety skin 
2. mild skin hyperextensibility 
3. unexplained striae distensae 
4. bilateral piezogenic papules 
(heel) 
5. recurrent or multiple 
abdominal hernias 
6. atrophic scarring at 2 or more 
sites without truly papyraceous 
and/or hemosideric scars 
7. pelvic floor, rectal and/or 
uterine prolapse in children, 
1. Generalized joint 
hypermobility AND 
2. Two or more 
among features A-C 
(A+B, A+C, B+C, 
A+B+C) must be 
present 
A: total of 5 must be 
present 
B: must be present 
C: 1 or more must be 
present 
AND 
3. absence of unusual 
skin fragility AND 
Not possible; hEDS is a 
clinical diagnosis. 
Sleep disturbance, fatigue, 
postural orthostatic 
tachycardia, functional 
gastro-intestinal disorders, 
dysautonomia, anxiety and 
depression are not part of the 
diagnostic criteria, but its 
presence may prompt 
consideration of hEDS in the 
differential diagnosis. 
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cut-off AND the 5-
point questionnaire 
(5PQ)* is positive then 
a diagnosis of GJH 
can be made 
men or nulliparous women 
without obesity or other 
explanation 
8. dental crowding and 
high/narrow palate 
9. arachnodactyly (bilateral 
positive wrist or thumb sign) 
10. arm span-to-height ≥ 1.05 
11. mitral valve prolapse (strict 
echocardiographic criteria) 
12. aortic root dilatation with Z-
score > +2 
B: one or more first degree 
relatives independently meeting 
the criteria for hEDS 
C: musculoskeletal 
complications 
1. pain in 2 or more limbs, 
recurring daily for at least 3 
months 
2. chronic widespread pain for 
≥ 3 months 
3. recurrent joint dislocations or 
frank joint instability in the 
absence of trauma (a or b) 
a. 3 or more dislocations in the 
same joint or 2 or more 
dislocations in 2 different joints 
occurring at different times 
b. medical confirmation of joint 
instability at 2 or more sites 
exclusion of other 
heritable and acquired 
connective tissue 
disorders, including 
autoimmune 
rheumatologic 
disorders# AND 
exclusion of 
alternative diagnoses 
e.g. neuromuscular 
disorders, other 
Heritable Connective 
Tissue Disorders, and 
skeletal dysplasias 
 
Arthrocha
lasia EDS 
Congenital bilateral 
hip dislocation 
Severe generalized 
joint hypermobility 
with multiple 
dislocations/ 
subluxations 
Skin 
hyperextensibility 
Muscle hypotonia 
Kyphoscoliosis 
Mild osteopenia (X-ray) 
Tissue fragility, including 
atrophic scars 
Easy bruisable skin 
 
Congenital bilateral 
hip dislocation plus 
either skin 
hyperextensibility or 
severe generalized 
joint hypermobility 
with multiple 
dislocations/ 
subluxations and at 
least 2 other minor 
criteria 
Molecular screening by 
Sanger sequencing of 
COL1A1/A2 or targeted 
resequencing of a EDS gene 
panel, including COL1A1/A2.    
If necessary CNV analysis for 
deletions and duplications.  
Supportive might be SDS 
PAGE analysis of cultured 
skin fibroblasts and TEM of 
skin biopsies 
Dermatos
paraxis 
EDS 
Extreme skin fragility 
with congenital or 
postnatal skin tears 
Characteristic 
craniofacial features  
Redundant, almost lax 
skin, 
Increased palmar 
wrinkling 
Severe bruisability 
Umbilical hernia 
Postnatal growth 
retardation 
Short limbs, hands 
and feet 
Perinatal 
complications due to 
connective tissue 
fragility 
Soft and doughy skin texture 
Skin hyperextensibility 
Atrophic scars 
Generalized joint hypermobility 
Complications of visceral 
fragility (bladder/diaphragmatic 
rupture, rectal prolapse) 
Delayed motor development 
Osteopenia 
Hirsutism  
Tooth abnormalities 
Refractive errors (myopia, 
astigmatism) 
Strabismus 
 
Extreme skin fragility 
with congenital or 
postnatal skin tears 
AND characteristic 
craniofacial features 
plus either 1 other 
major and/or 3 minor 
criteria 
Molecular screening by 
Sanger sequencing of 
ADAMTS2 or targeted 
resequencing of a EDS gene 
panel, including ADAMTS2.    
If necessary CNV analysis for 
deletions and duplications.  
Supportive might be SDS 
PAGE analysis of cultured 
skin fibroblasts and TEM of 
skin biopsies 
Kyphosco
liotic EDS 
Congenital muscle 
hypotonia 
Congenital or early 
onset  kyphoscoliosis  
Generalized joint 
hypermobility with 
multiple dislocations/ 
subluxations 
 
Skin hyperextensibility 
Easy bruisable skin 
Rupture/aneurysm of a 
medium-sized artery 
Osteopenia/osteoporosis 
Blue sclerae 
Hernia (umbilical or inguinal) 
Pectus deformity 
Marfanoid habitus 
Talipes equinovarus 
Congenital muscle 
hypotonia AND 
congenital or early 
onset  kyphoscoliosis 
plus either 
generalized joint 
hypermobility and/or 
3 minor criteria 
(general or gene-
specific) 
Increased Dpyr/pyr (= 
LP/HP) ratio in urine by 
HPLC is highly sensitive for 
PLOD1 kEDS.  Molecular 
analysis: MLPA of PLOD1 
(duplication); if negative 
MLPA, targeted resequencing 
of a EDS gene panel, 
including PLOD1 and 
FKBP14, but also ZNF469, 
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Refractive errors (myopia, 
hypermetropia) 
PLOD1 specific minor criteria 
Skin fragility (e.g. atrophic 
scarring, friable skin) 
Scleral/ocular fragility/rupture 
Microcornea  
Facial dysmorphology (e.g. 
low-set ears, epicanthal folds, 
down-slanting fissures, 
synophrys, high palate) 
FKBP14 specific minor 
criteria 
Congenital sensorineural, 
conductive or mixed hearing 
impairment  
Follicular hyperkeratosis 
Muscle atrophy 
Bladder diverticula 
PRDM5, B4GALT7, 
B3GALT6, SLC39A13, 
CHST14 and DSE, because of 
overlapping phenotypes.    
If necessary CNV analysis for 
deletions and duplications.  
Supportive might be TEM of 
skin biopsies 
Brittle 
Cornea 
syndrome 
Thin cornea with or 
without rupture 
Early onset 
progressive 
keratoconus 
Early onset 
progressive 
keratoglobus 
Blue sclerae 
Enucleation or corneal scarring 
Progressive loss of corneal 
stroma depth 
High myopia 
Retinal detachment 
Progressive high frequency 
often mixed deafness 
Hypercompliant tympanic 
membranes 
Developmental hip dysplasia 
Mild hypotonia in infancy 
Scoliosis 
Arachnodactyly 
Hypermobility of distal joints 
Pes planus, hallux valgus 
Mild finger contractures (esp. 
5th)  
Thin cornea with or 
without rupture plus 
either at least one 
other major criterion 
and/or 3 minor criteria 
Molecular screening by 
targeted resequencing of a 
EDS gene panel, including 
ZNF469 and PRDM5, but 
also PLOD1, FKBP14, 
B4GALT7, B3GALT6, 
SLC39A13, CHST14 and 
DSE, because of overlapping 
phenotypes. 
If necessary CNV analysis for 
deletions and duplications.     
 
Spondylo
dysplastic 
EDS 
Progressive short 
stature 
Muscle hypotonia 
(ranging severe 
congenital to mild 
later-onset) 
Bowing of limbs 
Skin hyperextensibility, soft 
doughy, thin translucent skin 
Pes planus 
Delayed motor development 
Osteopenia 
Delayed cognitive development 
B4GALT7 specific minor 
criteria 
Radioulnar synostosis 
Bilateral elbow contractures or 
limited elbow movement 
Generalized joint hypermobility 
Single transverse palmar crease 
Characteristic facial features 
Characteristic radiographic 
findings 
Severe hypermetropia 
Clouded cornea 
B3GALT6 specific minor 
criteria 
Kyphoscoliosis 
Joint hypermobility, generalized 
or restricted to distal joints 
Joint contractures (esp. hands) 
Peculiar fingers (e.g. slender, 
tapered, spatulate, broad distal 
phalanges) 
Talipes equinovarus 
Characteristic facial features 
Tooth discoloration, dysplastic 
teeth 
Characteristic radiographic 
findings 
Osteoporosis (spontaneous 
fractures) 
Short stature AND 
muscle hypotonia 
plus characteristic 
radiographic 
abnormalities and at 
least 3 other minor 
criteria (general or 
gene-specific) 
Molecular screening by 
targeted resequencing of a 
EDS gene panel, including 
B4GALT7, B3GALT6 and 
SLC39A13 but also PLOD1, 
FKBP14, ZNF469, PRDM5,  
CHST14 and DSE, because of 
overlapping phenotypes. 
If necessary CNV analysis for 
deletions and duplications.     
GAG deficiency  with 
B4GALT7 and  B3GALT6 
mutations in cultured 
fibroblasts. 
Moderately increased LP/HP 
ratio (to approximately 1 
compared to normal values of 
~ 0.2) with HLPC for 
SLC39A13 mutations. 
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* The Five-Point Questionnaire (5PQ):  
1. Can you now (or could you ever) place your hands flat on the floor without bending your knees?  
2. Can you now (or could you ever) bend your thumb to touch your forearm?   
3. As a child, did you amuse your friends by contorting your body into strange shapes or could you do the splits?  
4. As a child or teenager, did your shoulder or kneecap dislocate on more than one occasion?  
5. Do you consider yourself “double-jointed”?    
A “yes” answer to two or more questions (= positive 5PQ) suggests joint hypermobility with 80–85% sensitivity and 
80–90% specificity. 
Adapted from Hakim AJ, Grahame R. A simple questionnaire to detect hypermobility: an adjunct to the assessment 
of patients with diffuse musculoskeletal pain. Int J Clin Pract 57:163-166, 2003. 
# In patients with an acquired connective tissue disorder (e.g. lupus, rheumatoid arthritis) additional diagnosis of hEDS 
requires meeting both features A and B of criterion 2. Feature C of criterion 2 (chronic pain and/or instability) cannot 
be counted towards a diagnosis of hEDS in this situation. 
 
Ascending aortic aneurysm 
Lung hypoplasia, restrictive 
lung disease 
SLC39A13 specific minor 
criteria 
Protuberant eyes with bluish 
sclerae 
Hands with finely wrinkled 
palms 
Atrophy of thenar muscles, 
tapering fingers 
Hypermobility of distal joints 
Characteristic radiographic 
findings 
Musculoc
ontractura
l EDS 
Congenital multiple 
contractures 
(adduction-flexion 
and/or clubfoot) 
Characteristic 
craniofacial features 
Characteristic 
cutaneous features 
(hyperextensibility, 
bruising, fragility, 
atrophic scars, 
increased palmar 
wrinkling) 
 
Recurrent/chronic dislocations 
Pectus deformities (flat, 
excavatum) 
(Kypho)scoliosis 
Tapering, slender, cylindrical 
fingers 
Progressive talipes deformities 
(valgus, planus, cavum) 
Large subcutaneous hematomas 
Chronic constipation 
Colonic diverticula 
Pneumo(hemo)thorax 
Nephro/cystolithiasis 
Hydronephrosis 
Cryptorchidism  
Strabismus 
Refractive errors (myopia, 
astigmatism) 
Glaucoma/elevated intraocular 
pressure 
At birth or in early 
childhood 
Congenital multiple 
contractures AND 
characteristic 
craniofacial features  
In adolescence and 
adulthood 
Congenital multiple 
contractures AND 
characteristic 
cutaneous features 
 
Molecular screening by 
targeted resequencing of a 
EDS gene panel, including 
CHST14 and DSE but also 
PLOD1, FKBP14, ZNF469, 
PRDM5, B4GALT7, 
B3GALT6 and SLC39A13 , 
because of overlapping 
phenotypes. 
If necessary CNV analysis for 
deletions and duplications.     
 
Myopathi
c EDS 
Congenital muscle 
hypotonia and/or 
muscle atrophy that 
improves with age 
Proximal joint 
contractures (knee, 
hip, elbow) 
Hypermobility of 
distal joints 
Soft, doughy skin 
Atrophic scarring 
Delayed motor developmental 
Myopathy on muscle biopsy 
Congenital muscle 
hypotonia and/or 
muscle atrophy that 
improves with age 
plus either one other 
major criterion and/or 
three minor criteria 
 
Molecular screening by 
targeted resequencing of a 
EDS gene panel, including 
COL12A1, and 
COL6A1/A2/A3, because of 
overlapping phenotypes 
(Bethlem and Ullrich) .  
If necessary CNV analysis for 
deletions and duplications.     
Periodont
al EDS 
Severe, intractable 
periodontitis of early 
onset (childhood or 
adolescence) 
Lack of attached 
gingiva 
Pretibial plaques 
First degree relative 
who meets clinical 
criteria 
Easy bruising 
Joint hypermobility, mostly 
distal 
Skin hyperextensibility and 
fragility, wide or atrophic 
scarring 
Increased rate of infection 
Hernias 
Marfanoid facial features 
Acrogeria 
Prominent vasculature 
Severe, intractable 
periodontitis of early 
onset (childhood or 
adolescence) OR lack 
of attached gingiva 
Plus at least 2 other 
major criteria and one 
minor criterion 
 
Identification of known or 
compatible gain-of-function 
mutations by sequence 
analysis of C1R and C1S 
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